Indeed, the down-regulation of cyclin D1, which was accompanied by a substantial decrease of its target protein phospho-RB, was observed after a SINE agent KPT-185 treatment in MCL cells [53]. This evidence concerns the gene CCND1 and mantle cell lymphoma.